We achieved significant reduction of the primary tumor volume with desARE3'UTRERBB2-30, achieving 50% complete tumor lysis and inhibiting 60%–80% of liver metastasis, hepatomegaly, and 90% of lung metastasis, through ERBB2 downregulation. Here, ERBB2 is linked to neoplasm.